You are not logged in. | Log in
In Progress
Clinical

ER+, LNN, adjuvant tamoxifen

Purpose

The purpose of this study was to assess the benefit from adjuvant systemic tamoxifen therapy in breast cancer risk groups identified by the previously established prognostic 76-gene signature.

Hypothesis

The hypothesis of this study is that the 76-gene signature can predict survival and benefit from adjuvant endocrine therapy in LNN ER-positive patients who received adjuvant systemic therapy with tamoxifen alone.

Experimental Design

This dataset consists of a cohort of 136 breast cancer patients treated with adjuvant tamoxifen. Frozen tumor specimens were selected from the tumor banks in three of the four European institutions that provided the samples of patients without systemic therapy, i.e., Institute of Oncology, Ljubljana, Slovenia (36 samples; 1997–1999), National Cancer Institute, Bari, Italy (28 samples; 1990–1998), and Technische Universitaet Muenchen, Germany (9 samples; 1992–1999), and from one US institution, Cleveland Clinic Foundation (63 samples; 1981–2000). The distant metastasis-free survival (DMFS) among patients from different institutions was not different (log rank P = 0.63). All samples were drawn from the consecutive series of patients available in the institutions within the respective periods based on pre-defined inclusion criteria: histological diagnosis of LNN breast cancer, ER-positive primary tumor, adjuvant tamoxifen treatment, informed consent and/or approval by a local Ethical Committee, at least 5 years of follow-up except for patients who developed distant relapse within 5 years, no signs of disease within 1 month after primary surgery, and frozen tissue should be available. Exclusion criteria were: neoadjuvant or adjuvant chemotherapy, history of other primary cancer (except for basal cell carcinoma), less than 50% tumor area on hematoxylin/eosin (HE) section at time of extraction of RNA, or poor RNA quality.

Experimental Variables

--

Controls

--

Methods

Total RNA was extracted from tumor tissues (median 90 mg; range 40–120 mg) at the Erasmus MC, Rotterdam, as described by Wang et al and at Cleveland Clinic Foundation, Cleveland, and was sent to Veridex LLC, San Diego, for further analysis. The median RNA yield was 82 ?g (range 19–240 ?g). RNA quality was checked by use of the Agilent BioAnalyzer, and samples were profiled only if they had clear distinct 18S and 28S peaks with no minor peaks present, the area under the 18S and 28S peaks was more than 15% of the total RNA area, and if the 28S/18S ratio was between 1.2 and 2.0. Biotinylated targets were prepared using published methods (Affymetrix, CA) and hybridized to Affymetrix U133A GeneChips (Affymetrix, CA). Chips with average intensity of less than 40 or background signal of more than 100 were excluded. Each probe set was considered as a separate gene. Expression values for each gene were calculated using Affymetrix GeneChip analysis software MAS 5.0. For scaling, probe sets were scaled to a target intensity of 600 and scale mask filters were not selected.

The microarray data were nonlinearly normalized, using a cubic B-spline smoother, to ensure the same signal intensity distribution as the original discovery dataset used to establish the 76-gene signature (Wang et al).

Additional Information

Zhang, Yi, Anieta M. Sieuwerts, Michelle McGreevy, Graham Casey, Tanja Cufer, Angelo Paradiso, Nadia Harbeck, et al. “The 76-Gene Signature Defines High-Risk Patients That Benefit from Adjuvant Tamoxifen Therapy.” Breast Cancer Research and Treatment 116, no. 2 (July 2009): 303–9. doi:10.1007/s10549-008-0183-2.

Wang, Yixin, Jan G. M. Klijn, Yi Zhang, Anieta M. Sieuwerts, Maxime P. Look, Fei Yang, Dmitri Talantov, et al. “Gene-Expression Profiles to Predict Distant Metastasis of Lymph-Node-Negative Primary Breast Cancer.” Lancet (London, England) 365, no. 9460 (February 19, 2005): 671–79. doi:10.1016/S0140-6736(05)17947-1.

Microarray
Affymetrix HG-U133A
136 Samples Loaded: 136
Human (Homo sapiens)
Breast Cancer Tissue , Institute of Oncology, Ljubljana, Slovenia , Cleveland Clinic Foundation, Cleveland, OH, USA , National Cancer Institute, Bari, Italy , Technische Universitaet Muenchen, Germany , Nagalla 2013
ER+ Breast Cancer
Sample Set Spreadsheet
Please log in in order to upload files.
Samples Preview
Sample ID series IMS IBS IDS ICR
GSM305129 NA Basal IBE PID ICR2
GSM305130 NA LumA IBD PID ICR2
GSM305131 NA Basal IBE WID ICR4
GSM305132 NA LumB IBE FID ICR4
GSM305133 NA Her2 IBD PID ICR1
Please log in in order to upload files.
File
GSE12093_appended.meta.data_v1.csv
Sample Set Spreadsheet
Average Normalized
  •   |  View in GXB »
Clinical Datasource
Links

Samples Viewer / Editor

All fields are editable except the "Sample ID" column. To edit a cell, click within the cell. To edit a "date" cell, click on the calendar icon. To cancel an edit, press the ESC key.

Sample ID Series IMS IBS IDS ICR Array Sample ID Sample Title DMFS 10Y EVENT DMFS 10Y TIME Disease Free Survival Event Distant Met Free Survival Event Distant Met Free Survival Age At Initial Pathologic Diagnosis Lymph Node Status ER Status PR Status Histology Differentiation Grade Tumor Size Cm Pathology T Stage Disease Free Survival Days
GSM305129
NA
Basal
IBE
PID
ICR2
400002656
breast tumor sample 3001
DistantMetastasisFree
5
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
60
GSM305130
NA
LumA
IBD
PID
ICR2
400002657
breast tumor sample 3002
DistantMetastasisFree
5.72
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
686
GSM305131
NA
Basal
IBE
WID
ICR4
400002658
breast tumor sample 3003
DistantMetastasisFree
5.28
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
633
GSM305132
NA
LumB
IBE
FID
ICR4
400002659
breast tumor sample 3004
DistantMetastasisFree
5.11
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
613
GSM305133
NA
Her2
IBD
PID
ICR1
400002660
breast tumor sample 3005
DistantMetastasisFree
5.58
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
669
GSM305134
NA
LumB
IBD
PID
ICR2
400002661
breast tumor sample 3006
DistantMetastasisFree
5.26
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
631
GSM305135
NA
LumB
IBE
PID
ICR1
400002662
breast tumor sample 3007
DistantMetastasis
5.05
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
606
GSM305136
NA
LumA
IBD
PID
ICR1
400002663
breast tumor sample 3009
DistantMetastasisFree
5.29
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
635
GSM305137
NA
Her2
IBD
PID
ICR2
400002664
breast tumor sample 3012
DistantMetastasisFree
5.35
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
642
GSM305138
NA
Normal
IBE
NA
ICR3
400002665
breast tumor sample 3013
DistantMetastasisFree
5.15
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
618
GSM305139
NA
NA
IBE
NA
ICR2
400002666
breast tumor sample 3014
DistantMetastasisFree
5
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
60
GSM305140
NA
Her2
IBD
WID
ICR3
400002667
breast tumor sample 3015
DistantMetastasis
3.72
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
446
GSM305141
NA
Her2
IBD
PID
ICR1
400002668
breast tumor sample 3329
DistantMetastasisFree
5.28
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
633
GSM305142
NA
Normal
IBE
NA
ICR2
400002669
breast tumor sample 3331
DistantMetastasisFree
5.68
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
681
GSM305143
NA
LumA
IBD
PID
ICR1
400002670
breast tumor sample 3333
DistantMetastasisFree
5.66
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
679
GSM305144
NA
Basal
IBE
WID
ICR3
400002671
breast tumor sample 3335
DistantMetastasisFree
6.75
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
81
GSM305145
NA
LumB
IBD
PID
ICR1
400002672
breast tumor sample 3336
DistantMetastasisFree
6.9
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
828
GSM305146
NA
LumB
IBE
FID
ICR4
400002673
breast tumor sample 3337
DistantMetastasisFree
5.49
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
659
GSM305147
NA
LumA
IBD
PID
ICR3
400002674
breast tumor sample 3338
DistantMetastasisFree
6.58
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
79
GSM305148
NA
NA
IBE
NA
ICR1
400002675
breast tumor sample 3340
DistantMetastasisFree
5.13
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
616
GSM305149
NA
Normal
IBE
NA
ICR3
400002676
breast tumor sample 3343
DistantMetastasisFree
7.02
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
842
GSM305150
NA
LumA
IBD
PID
ICR2
400002677
breast tumor sample 3250
DistantMetastasisFree
9.16
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1099
GSM305151
NA
LumB
IBD
WID
ICR3
400002678
breast tumor sample 3251
DistantMetastasis
5.41
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
649
GSM305152
NA
Basal
IBE
WID
ICR3
400002679
breast tumor sample 3252
DistantMetastasisFree
5.6
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
672
GSM305153
NA
Her2
IBE
PID
ICR3
400002680
breast tumor sample 3253
DistantMetastasis
1.91
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
229
GSM305154
NA
LumA
IBD
PID
ICR1
400002681
breast tumor sample 3254
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1246
GSM305155
NA
Normal
IBE
NA
ICR3
400002682
breast tumor sample 3256
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1229
GSM305156
NA
Basal
IBE
PID
ICR3
400002683
breast tumor sample 3257
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1214
GSM305157
NA
Basal
IBE
WID
ICR4
400002684
breast tumor sample 3258
DistantMetastasis
0.63
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
76
GSM305158
NA
LumA
IBD
PID
ICR2
400002685
breast tumor sample 3259
DistantMetastasisFree
9.97
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1196
GSM305159
NA
LumA
IBD
WID
ICR2
400002686
breast tumor sample 3260
DistantMetastasisFree
9.86
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1183
GSM305160
NA
LumB
IBD
PID
ICR2
400002687
breast tumor sample 3261
DistantMetastasisFree
5.18
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
621
GSM305161
NA
Her2
IBD
WID
ICR2
400002688
breast tumor sample 3262
DistantMetastasisFree
9.71
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1165
GSM305162
NA
Her2
IBE
FID
ICR4
400002689
breast tumor sample 3263
DistantMetastasisFree
5.16
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
619
GSM305163
NA
LumA
IBD
PID
ICR1
400002690
breast tumor sample 3265
DistantMetastasisFree
8.24
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
989
GSM305164
NA
LumB
IBE
PID
ICR3
400002691
breast tumor sample 3266
DistantMetastasis
3
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
36
GSM305165
NA
LumB
IBD
PID
ICR1
400002692
breast tumor sample 3267
DistantMetastasisFree
6.72
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
806
GSM305166
NA
Basal
IBE
WID
ICR3
400002693
breast tumor sample 3269
DistantMetastasisFree
8.43
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1012
GSM305167
NA
LumA
IBD
PID
ICR1
400002694
breast tumor sample 3270
DistantMetastasisFree
6.43
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
772
GSM305168
NA
Her2
IBD
PID
ICR2
400002695
breast tumor sample 3271
DistantMetastasisFree
5.35
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
642
GSM305169
NA
Basal
IBE
PID
ICR1
400002696
breast tumor sample 3272
DistantMetastasisFree
9.71
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1165
GSM305170
NA
LumA
IBD
PID
ICR3
400002697
breast tumor sample 3273
DistantMetastasisFree
9.18
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1101
GSM305171
NA
LumB
IBD
PID
ICR2
400002698
breast tumor sample 3274
DistantMetastasisFree
9.15
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1098
GSM305172
NA
LumB
IBE
WID
ICR3
400002699
breast tumor sample 3275
DistantMetastasis
6.33
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
759
GSM305173
NA
Her2
IBE
PID
ICR3
400002700
breast tumor sample 3276
DistantMetastasisFree
7.9
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
948
GSM305174
NA
Basal
IBE
FID
ICR4
400002701
breast tumor sample 3277
DistantMetastasisFree
7.6
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
912
GSM305175
NA
LumB
IBE
PID
ICR1
400002702
breast tumor sample 3278
DistantMetastasisFree
6.95
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
834
GSM305176
NA
LumA
IBD
PID
ICR1
400002703
breast tumor sample 3279
DistantMetastasisFree
7.26
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
871
GSM305177
NA
Basal
IBE
FID
ICR4
400002704
breast tumor sample 3280
DistantMetastasisFree
7.13
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
856
GSM305178
NA
Normal
IBE
NA
ICR2
400002705
breast tumor sample 100
DistantMetastasisFree
9.47
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1136
GSM305179
NA
LumA
IBD
WID
ICR2
400002706
breast tumor sample 108
DistantMetastasisFree
9.07
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1088
GSM305180
NA
LumA
IBD
WID
ICR2
400002707
breast tumor sample 123
DistantMetastasis
2.45
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
294
GSM305181
NA
Basal
IBE
FID
ICR3
400002708
breast tumor sample 128
DistantMetastasisFree
8.59
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1031
GSM305182
NA
Basal
IBE
FID
ICR4
400002709
breast tumor sample 129
DistantMetastasisFree
8.53
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1023
GSM305183
NA
LumB
IBD
PID
ICR2
400002710
breast tumor sample 57
DistantMetastasisFree
7.74
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
929
GSM305184
NA
Normal
IBE
NA
ICR3
400002711
breast tumor sample 65
DistantMetastasisFree
8.68
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1041
GSM305185
NA
LumA
IBD
PID
ICR1
400002712
breast tumor sample 71
DistantMetastasisFree
8.21
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
985
GSM305186
NA
Normal
IBE
NA
ICR3
400002713
breast tumor sample 172
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1389
GSM305187
NA
Basal
IBE
FID
ICR4
400002714
breast tumor sample 175
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1283
GSM305188
NA
Normal
IBE
NA
ICR3
400002715
breast tumor sample 9253
DistantMetastasisFree
9.1
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1092
GSM305189
NA
Normal
IBE
NA
ICR2
400002716
breast tumor sample 9442
DistantMetastasisFree
9.51
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1141
GSM305190
NA
Normal
IBE
NA
ICR3
400002717
breast tumor sample 2143
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
154
GSM305191
NA
Normal
IBE
NA
ICR2
400002718
breast tumor sample 2162
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1489
GSM305192
NA
LumB
IBE
PID
ICR3
400002719
breast tumor sample 2048
DistantMetastasis
2.43
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
291
GSM305193
NA
ClaudinLow
IBD
FID
ICR4
400002720
breast tumor sample 2534
DistantMetastasisFree
6.52
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
782
GSM305194
NA
LumB
IBD
PID
ICR1
400002721
breast tumor sample 2536
DistantMetastasis
8.68
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
1041
GSM305195
NA
Normal
IBE
NA
ICR3
400002722
breast tumor sample 2556
DistantMetastasisFree
5.21
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
625
GSM305196
NA
LumA
IBD
WID
ICR2
400002723
breast tumor sample 2588
DistantMetastasisFree
6.35
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
762
GSM305197
NA
LumA
IBD
FID
ICR3
400002724
breast tumor sample 2647
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1926
GSM305198
NA
NA
IBE
NA
ICR4
400002725
breast tumor sample 2494
DistantMetastasis
9.05
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
1086
GSM305199
NA
NA
IBE
NA
ICR3
400002726
breast tumor sample 2733
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1919
GSM305200
NA
LumB
IBD
PID
ICR1
400002727
breast tumor sample 2639
DistantMetastasisFree
10
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
1395
GSM305201
NA
NA
IBE
NA
ICR3
400002728
breast tumor sample 2872
DistantMetastasisFree
5.18
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
622
GSM305202
NA
LumA
IBD
WID
ICR2
400002729
breast tumor sample 2236
DistantMetastasisFree
9
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
108
GSM305203
NA
Basal
IBE
PID
ICR2
400002730
breast tumor sample 2308
DistantMetastasisFree
10
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
1643
GSM305204
NA
Basal
IBE
WID
ICR3
400002731
breast tumor sample 41826
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
151
GSM305205
NA
Normal
IBE
NA
ICR2
400002732
breast tumor sample 21514
DistantMetastasisFree
8.15
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
978
GSM305206
NA
Normal
IBE
NA
ICR2
400002733
breast tumor sample 21590
DistantMetastasisFree
5.94
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
713
GSM305207
NA
LumA
IBD
PID
ICR1
400002734
breast tumor sample 21604
DistantMetastasis
3.95
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
474
GSM305208
NA
Normal
IBE
NA
ICR2
400002735
breast tumor sample 21572
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1297
GSM305209
NA
Her2
IBE
PID
ICR1
400002736
breast tumor sample 9191
DistantMetastasisFree
9.68
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1162
GSM305210
NA
LumB
IBD
WID
ICR2
400002737
breast tumor sample 21815
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1304
GSM305211
NA
LumA
IBD
PID
ICR1
400002738
breast tumor sample 21790
DistantMetastasis
5.77
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
692
GSM305212
NA
LumA
IBD
PID
ICR1
400002739
breast tumor sample 21148
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1913
GSM305213
NA
Normal
IBE
NA
ICR3
400002740
breast tumor sample 2492
DistantMetastasisFree
5.01
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
601
GSM305214
NA
Normal
IBE
NA
ICR2
400002741
breast tumor sample 2056
DistantMetastasisFree
5.1
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
612
GSM305215
NA
Normal
IBE
NA
ICR1
400002742
breast tumor sample 2548
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1773
GSM305216
NA
Her2
IBE
PID
ICR2
400002743
breast tumor sample 21279
DistantMetastasis
3.18
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
382
GSM305217
NA
LumB
IBE
PID
ICR1
400002744
breast tumor sample 21276
DistantMetastasis
2.58
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
309
GSM305218
NA
Basal
IBE
WID
ICR3
400002745
breast tumor sample 2342
DistantMetastasisFree
5.16
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
619
GSM305219
NA
Normal
IBE
NA
ICR2
400002746
breast tumor sample 2455
DistantMetastasisFree
7.65
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
918
GSM305220
NA
Normal
IBE
NA
ICR2
400002747
breast tumor sample 2354
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1608
GSM305221
NA
Normal
IBE
NA
ICR2
400002748
breast tumor sample 2386
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1323
GSM305222
NA
LumA
IBD
PID
ICR1
400002749
breast tumor sample 2420
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1628
GSM305223
NA
LumA
IBD
WID
ICR1
400002750
breast tumor sample 2237
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1416
GSM305224
NA
LumB
IBD
WID
ICR3
400002751
breast tumor sample 2297
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1356
GSM305225
NA
LumB
IBD
WID
ICR3
400002752
breast tumor sample 2392
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1821
GSM305226
NA
Normal
IBE
NA
ICR2
400002753
breast tumor sample 2377
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1763
GSM305227
NA
LumA
IBD
WID
ICR2
400002754
breast tumor sample 8
DistantMetastasisFree
8.8
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1056
GSM305228
NA
Normal
IBE
NA
ICR2
400002755
breast tumor sample 19
DistantMetastasisFree
9.4
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1128
GSM305229
NA
Normal
IBE
NA
ICR3
400002756
breast tumor sample 33
DistantMetastasisFree
8.06
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
967
GSM305230
NA
Normal
IBE
NA
ICR2
400002757
breast tumor sample 37
DistantMetastasisFree
8.61
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1033
GSM305231
NA
LumB
IBD
PID
ICR2
400002758
breast tumor sample 38
DistantMetastasisFree
8.34
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1001
GSM305232
NA
Basal
IBE
WID
ICR3
400002759
breast tumor sample 46
DistantMetastasisFree
5.26
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
631
GSM305233
NA
LumA
IBD
PID
ICR1
400002760
breast tumor sample 87
DistantMetastasisFree
9.69
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1163
GSM305234
NA
LumA
IBD
FID
ICR4
400002761
breast tumor sample 88
DistantMetastasisFree
8.39
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1007
GSM305235
NA
Normal
IBE
NA
ICR2
400002762
breast tumor sample 92
DistantMetastasisFree
8.67
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
104
GSM305236
NA
Basal
IBE
WID
ICR2
400002763
breast tumor sample 2160
DistantMetastasis
1.1
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
132
GSM305237
NA
Normal
IBE
NA
ICR2
400002764
breast tumor sample 2309
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1635
GSM305238
NA
LumB
IBE
WID
ICR3
400002765
breast tumor sample 3344
DistantMetastasisFree
6.88
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
825
GSM305239
NA
LumA
IBD
WID
ICR3
400002766
breast tumor sample 3346
DistantMetastasisFree
5.07
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
608
GSM305240
NA
Her2
IBE
PID
ICR3
400002767
breast tumor sample 3347
DistantMetastasisFree
7.47
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
896
GSM305241
NA
LumA
IBD
PID
ICR2
400002768
breast tumor sample 3348
DistantMetastasisFree
6.95
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
834
GSM305242
NA
LumB
IBE
PID
ICR1
400002769
breast tumor sample 3349
DistantMetastasisFree
7.78
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
934
GSM305243
NA
Basal
IBE
WID
ICR4
400002770
breast tumor sample 3350
DistantMetastasis
1.25
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
15
GSM305244
NA
LumB
IBD
PID
ICR1
400002771
breast tumor sample 3351
DistantMetastasisFree
5.22
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
626
GSM305245
NA
LumB
IBE
PID
ICR1
400002772
breast tumor sample 3352
DistantMetastasisFree
6.96
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
835
GSM305246
NA
Basal
IBE
PID
ICR2
400002773
breast tumor sample 3353
DistantMetastasisFree
6.99
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
839
GSM305247
NA
Her2
IBD
PID
ICR2
400002774
breast tumor sample 3354
DistantMetastasisFree
6.88
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
825
GSM305248
NA
Basal
IBE
FID
ICR4
400002775
breast tumor sample 3355
DistantMetastasisFree
7.52
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
902
GSM305249
NA
LumB
IBD
PID
ICR1
400002776
breast tumor sample 3356
DistantMetastasisFree
6.62
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
794
GSM305250
NA
LumA
IBD
WID
ICR2
400002777
breast tumor sample 3357
DistantMetastasisFree
5.16
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
619
GSM305251
NA
LumB
IBD
PID
ICR1
400002778
breast tumor sample 3360
DistantMetastasisFree
6.21
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
745
GSM305252
NA
LumB
IBE
WID
ICR3
400002779
breast tumor sample 3362
DistantMetastasisFree
5.26
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
631
GSM305253
NA
LumB
IBE
WID
ICR3
400002780
breast tumor sample 3363
DistantMetastasisFree
7.02
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
842
GSM305254
NA
LumB
IBE
PID
ICR3
400002781
breast tumor sample 3364
DistantMetastasisFree
7.55
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
906
GSM305255
NA
LumB
IBE
WID
ICR3
400002782
breast tumor sample 3365
DistantMetastasisFree
5.64
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
677
GSM305256
NA
LumB
IBE
FID
ICR4
400002783
breast tumor sample 3366
DistantMetastasisFree
6.31
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
757
GSM305257
NA
LumB
IBE
PID
ICR1
400002784
breast tumor sample 3367
DistantMetastasisFree
6.76
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
811
GSM305258
NA
LumB
IBE
PID
ICR1
400002785
breast tumor sample 3368
DistantMetastasisFree
7.35
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
882
GSM305259
NA
Basal
IBE
FID
ICR4
400002786
breast tumor sample 3369
DistantMetastasisFree
7.38
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
885
GSM305260
NA
LumA
IBD
PID
ICR1
400002787
breast tumor sample 3370
DistantMetastasisFree
7.03
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
843
GSM305261
NA
Her2
IBD
PID
ICR2
400002788
breast tumor sample 3371
DistantMetastasisFree
6.97
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
836
GSM305262
NA
Basal
IBE
PID
ICR2
400002789
breast tumor sample 9
DistantMetastasisFree
8.89
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1067
GSM305263
NA
Basal
IBE
PID
ICR2
400002790
breast tumor sample 42
DistantMetastasis
2.47
Progressed/Recurred
NA
NA
NA
NA
NA
NA
NA
NA
NA
296
GSM305264
NA
Normal
IBE
NA
ICR2
400002791
breast tumor sample 77
DistantMetastasisFree
10
DiseaseFree
NA
NA
NA
NA
NA
NA
NA
NA
NA
1796

Group Sets View in Gene Expression Browser

Name  
All Samples Default  View
Immune Benefit Status   View
Immunological Constant of Rejection   View
Molecular Subtype   View
In order to make new Group Sets or change settings, please log in.

Module Analysis

Group Set  
All Samples
Immune Benefit Status
Immunological Constant of Rejection
Molecular Subtype
Your bug report has been sent!